Issue 6, 2002

Novel glucocorticoid antedrugs possessing a 21-(γ-lactone) ring

Abstract

A series of novel pregnane derivatives bearing γ-butyrolactones at C21 were prepared and tested as glucocorticoid agonists. The compounds were also tested for their lability in human plasma, and found to be rapidly hydrolysed by the enzyme paraoxonase to the respective hydroxyacids.

Graphical abstract: Novel glucocorticoid antedrugs possessing a 21-(γ-lactone) ring

Supplementary files

Article information

Article type
Paper
Submitted
04 Jan 2002
Accepted
11 Feb 2002
First published
26 Feb 2002

J. Chem. Soc., Perkin Trans. 1, 2002, 831-839

Novel glucocorticoid antedrugs possessing a 21-(γ-lactone) ring

R. M. Angell, K. Biggadike, R. M. Farrell, S. S. Flack, A. P. Hancock, W. R. Irving, S. M. Lynn and P. A. Procopiou, J. Chem. Soc., Perkin Trans. 1, 2002, 831 DOI: 10.1039/B200190J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements